ProteoGenix and Cizzle Biotechnology Collaboration Forges New Paths in Early Detection of Lung Cancer through Innovative Antibody Development
Pressat
Monday 29 April, 2024Schiltigheim, France, April 25th, 2024 – ProteoGenix, a leading antibody development contract research..